|
Dr. Davie is the former Senior Vice President, Department of Research, at Biogen, Inc. He has also served as President, R&D and Senior Vice President, Science and Technology at G.D. Searle, as well as Professor and Department Head of Microbiology and Immunology at Washington University School of Medicine. Dr. Davie has served on the Board of Directors of - various companies, including Auxeris Therapeutics, Inc., Beyond Genomics, Curis, Inc., Keel Pharmaceuticals, Stratatech, LLC., Targeted Genetics, Inc. and CV Therapeutics. Dr. Davie is a member of National Council, Washington University School of Medicine and the Institute of Medicine. | 